The CAR-TCR Summit Asia 2018 is dedicated to ensuring the clinical translation of CAR-T and TCR therapies to the market globally.
The CAR-TCR Summit Asia 2018 covers topics such as:
- Autologous vs Allogeneic: Identify the challenges and opportunities for cost effective and efficacious therapies
- Solid Tumors: Develop the next generation CAR-TCR therapies directed at novel targets to treat solid tumor indications
- Regulations: Maneuver through the global regulatory landscape to ensure approval success
- Manufacturing: Ensure streamlined scale up and out of engineered cell immunotherapies with innovative automation solutions